Vasostenoon

Vasostenoon may be available in the countries listed below.

Ingredient matches for Vasostenoon

Alprostadil

Alprostadil is reported as an ingredient of Vasostenoon in the following countries:

• Estonia


• Latvia

International Drug Name Search

Oxytrol System

Pronunciation: OX-i-BUE-ti-nin
Generic Name: Oxybutynin
Brand Name: Oxytrol

Oxytrol System is used for:

Relieving symptoms of bladder problems (urinary urgency, frequency, or leakage; loss of bladder control; and painful urination) in certain patients. It may also be used for other conditions as determined by your doctor.

Oxytrol System is an anticholinergic. It works by relaxing muscles in the bladder.

Do NOT use Oxytrol System if:

• you are allergic to any ingredient in Oxytrol System


• you have bladder blockage or are unable to urinate


• you have certain stomach or bowel problems (eg, blockage, decreased muscle movement)


• you have uncontrolled narrow-angle glaucoma


• you are taking a solid oral potassium product (eg, tablet)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Oxytrol System:

Some medical conditions may interact with Oxytrol System. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have trouble urinating or have very poor health


• if you have a history of heart problems (eg, heart failure, fast or irregular heartbeat), high blood pressure, nervous system problems, liver or kidney problems, myasthenia gravis, an enlarged prostate, an overactive thyroid, esophagus problems (eg, reflux disease, inflammation, narrowing), stomach or bowel problems (eg, colitis, inflammation, constipation), or a hiatal hernia


• if you have a history of glaucoma or increased pressure in the eyes, or if you are at risk of glaucoma (eg, family history of glaucoma)

Some MEDICINES MAY INTERACT with Oxytrol System. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Bisphosphonates (eg, alendronate) because the risk of irritation of the esophagus may be increased


• Other anticholinergic medicines (eg, scopolamine), azole antifungals (eg, ketoconazole), or macrolide antibiotics (eg, erythromycin) because they may increase the risk of Oxytrol System's side effects


• Solid oral potassium products (eg, tablets) because the risk of stomach or bowel irritation may be increased by Oxytrol System


• Phenothiazines (eg, chlorpromazine) because their effectiveness may be decreased by Oxytrol System and they may increase the risk of Oxytrol System's side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxytrol System may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Oxytrol System:

Use Oxytrol System as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Oxytrol System. Talk to your pharmacist if you have questions about this information.


• Apply the patch to a clean, dry, smooth area of your skin on your stomach, hips, or buttocks. Apply it to an area under clothing to protect it from sunlight. Avoid applying it to your waistline because clothing may rub against the patch.


• Do NOT apply the patch to oily, damaged, or irritated skin. Avoid using oils, lotions, or powders near the application site because the patch may not stick to your skin.


• To use Oxytrol System, open the pouch and remove the patch. Apply it right away. Carefully remove the first protective liner and place the patch firmly onto your skin. Do not touch the adhesive side of the patch. Bend the patch in half and gently roll the remaining part onto your skin. The second protective liner should come off of the patch. Gently apply firm pressure over the patch to be sure it stays in place.


• When it is time to apply a new patch, remove the old patch carefully. Fold the patch in half with the sticky sides together. Discard the patch out of the reach of children and pets because it may still contain medicine.


• Use a different skin site each time you apply a new patch. Do not reuse the same site within 7 days.


• Use Oxytrol System on a regular schedule to get the most benefit from it. Using Oxytrol System at the same time each day will help you remember to use it.


• Continue to use Oxytrol System even if you feel well. Do not miss any doses.


• If the patch comes off, press it back in place and continue to follow your regular application schedule. If it does not stay on, throw it away and put a new patch on in a different area. Continue to follow your regular application schedule.


• If you forget to change the patch on the correct day, remove the old patch and apply a new patch to a different application site as soon as you remember. Continue to follow your regular application schedule. Do not use 2 patches at once.

Ask your health care provider any questions you may have about how to use Oxytrol System.

Important safety information:

• Oxytrol System may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Oxytrol System with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Oxytrol System; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Oxytrol System may cause decreased sweating. Do not become overheated in hot weather or while you are being active; heatstroke may occur. Contact your doctor if you have been exposed to high temperatures and you develop fever; flushing; hot, dry skin; severe or persistent headache; dizziness; sudden fatigue; fast heartbeat; seizures; or fainting.


• Oxytrol System may cause dry mouth. To help relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute. Ask your doctor or pharmacist if you have any questions.


• A serious side effect called angioedema has been reported with the use of oral dosage forms of Oxytrol System (eg, tablets). Contact your doctor at once if you develop swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness.


• Using Oxytrol System while bathing, swimming, showering, or exercising will not change the way it works. However, avoid rubbing the patch area during these activities.


• Always remove the patch carefully and slowly to avoid damage to your skin. If there is adhesive left on your skin, gently wash the area with warm, soapy water. You may also use baby oil or a medical adhesive removal pad if needed. Do not use alcohol or nail polish remover because these may irritate the skin.


• After removing the patch, there may be minor redness of your skin. It should disappear after several hours. Tell your doctor if the irritation or redness becomes worse or if it does not go away.


• Use Oxytrol System with caution in the ELDERLY; they may be more sensitive to its effects.


• Oxytrol System should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: It is not known if Oxytrol System can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oxytrol System while you are pregnant. It is not known if Oxytrol System is found in breast milk. If you are or will be breast-feeding while you use Oxytrol System, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Oxytrol System:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; diarrhea; dizziness; drowsiness; dry eyes, nose, skin, or mouth; headache; indigestion; nausea; minor redness, itching, or irritation at patch application site; stomach pain.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); confusion; difficult or painful urination; fast or irregular heartbeat; fever; hallucinations; mental or mood changes (eg, agitation); pain, burning, blistering, or oozing at the application site; seizures; swelling of the hands, ankles, or feet; vision problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Oxytrol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; delirium; fever; flushing; hallucinations; inability to urinate; irregular heartbeat; paralysis; seizures; severe or persistent dizziness or headache; tremor; trouble breathing; vomiting.

Proper storage of Oxytrol System:

Store Oxytrol System at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store in original packaging until just before use. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oxytrol System out of the reach of children and away from pets.

General information:

• If you have any questions about Oxytrol System, please talk with your doctor, pharmacist, or other health care provider.


• Oxytrol System is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oxytrol System. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oxytrol resources

• Oxytrol Side Effects (in more detail)
• Oxytrol Use in Pregnancy & Breastfeeding
• Oxytrol Drug Interactions
• Oxytrol Support Group
• 9 Reviews for Oxytrol - Add your own review/rating

Compare Oxytrol with other medications

• Dysuria
• Overactive Bladder
• Urinary Incontinence

Terizidone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AK03

CAS registry number (Chemical Abstracts Service)

0025683-71-0

Chemical Formula

C14-H14-N4-O4

Molecular Weight

302

Therapeutic Category

Antitubercular agent

Chemical Name

3-Isoxazolidinone, 4,4'-[1,4-phenylenebis(methylidynenitrilo)]bis-

Foreign Names

• Terizidonum (Latin)
• Terizidon (German)
• Térizidone (French)
• Terizidona (Spanish)

Generic Names

• Terizidone (OS: DCIT)
• R 2360 (IS)

Brand Names

• Terivalidin
  Aventis, South Africa



• Terizidon
  Fatol, Lithuania; Fatol, Latvia; Riemser, Germany

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Codicompren

Codicompren may be available in the countries listed below.

Ingredient matches for Codicompren

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codicompren in the following countries:

• Germany

International Drug Name Search

Propofol Farma-Aps

Propofol Farma-Aps may be available in the countries listed below.

Ingredient matches for Propofol Farma-Aps

Propofol

Propofol is reported as an ingredient of Propofol Farma-Aps in the following countries:

• Portugal

International Drug Name Search

Ceva Leval

Ceva Leval may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ceva Leval

Albendazole

Albendazole is reported as an ingredient of Ceva Leval in the following countries:

• South Africa

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Ceva Leval in the following countries:

• South Africa

International Drug Name Search

Apo-Doxycycline

Apo-Doxycycline may be available in the countries listed below.

Ingredient matches for Apo-Doxycycline

Doxycycline

Doxycycline is reported as an ingredient of Apo-Doxycycline in the following countries:

• Guyana

International Drug Name Search

Cox

Cox may be available in the countries listed below.

Ingredient matches for Cox

Celecoxib

Celecoxib is reported as an ingredient of Cox in the following countries:

• Argentina

International Drug Name Search

Tilactase

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A09AA04

CAS registry number (Chemical Abstracts Service)

0009031-11-2

Therapeutic Categories

Enzyme

Drug for metabolic disease treatment

Chemical Name

ß-D-Galactosidase (WHO)

Foreign Names

• Tilactasum (Latin)
• Tilactase (German)
• Tilactase (French)
• Tilactasa (Spanish)

Generic Names

• Tilactase (OS: JAN)
• Galactosidase, ß-D- (IS)
• Lactase (PH: USP 32)
• ß-Galactosidase (Aspergillus) (PH: JP XV)
• ß-Galactosidase (Penicillium) (PH: JP XV)

Brand Names

• Carrashimease
  Tsuruhara Seiyaku, Japan



• Dairy Ease
  Blistex, United States



• Dairy Free
  SteriMax, Canada



• DairyCare
  Plainview, United States



• Deminase
  Fuso Pharmaceutical, Japan



• Galantase
  Tanabe Mitsubishi, Japan



• Lacdigest
  Grogg Pharma, Switzerland; Italchimici, Italy



• Lactaid
  McNeil, United States; McNeil Consumer Healthcare, Canada



• Lactas
  Dominguez, Argentina



• Lactase
  Strathmann, Hungary



• Lactosanol
  Schwarz, Poland



• Lactosi
  Inhospi, Guatemala; Inhospi, El Salvador



• Lactrase
  Schwarz, United States



• Lactyme
  Wakamoto, Japan



• Lisolac
  Pentafarma, Portugal



• Millact
  Shionogi Seiyaku, Japan



• N-Lactase
  Nisshin Seiyaku - Yamagata, Japan



• Oryzatym
  Yakult, Japan



• Silact
  Sofar, Italy



• TilactaMed
  Strathmann, Germany



• Tilactase Farmoz
  Farmoz, Portugal

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

ALK Soluprick Negativ kontrol

ALK Soluprick Negativ kontrol may be available in the countries listed below.

Ingredient matches for ALK Soluprick Negativ kontrol

Glycerol

Glycerol is reported as an ingredient of ALK Soluprick Negativ kontrol in the following countries:

• Denmark

International Drug Name Search

Tadol

Tadol may be available in the countries listed below.

Ingredient matches for Tadol

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tadol in the following countries:

• Denmark


• Slovenia

International Drug Name Search

Simet

Simet may be available in the countries listed below.

Ingredient matches for Simet

Simeticone

Simeticone is reported as an ingredient of Simet in the following countries:

• Poland

International Drug Name Search

Lactulosa

Lactulosa may be available in the countries listed below.

Ingredient matches for Lactulosa

Lactulose

Lactulose is reported as an ingredient of Lactulosa in the following countries:

• Chile


• Ecuador

International Drug Name Search

Efferalganodis

In the US, Efferalganodis is a member of the drug class miscellaneous analgesics and is used to treat Fever, Muscle Pain, Pain and Sciatica.

Ingredient matches for Efferalganodis

Paracetamol

Paracetamol is reported as an ingredient of Efferalganodis in the following countries:

• Benin


• Burkina Faso


• Burundi


• Cameroon


• Central African Republic


• Chad


• Congo


• Cote D'ivoire


• France


• Gabon


• Guinea


• Madagascar


• Mali


• Mauritania


• Mauritius


• Niger


• Senegal


• Togo


• Zaire

International Drug Name Search